✉news HealthMedicine first seen 1 d ago, last 1 d ago, peak #22

Nuravax Reports Phase 1 Results for Alzheimer's Vaccine AV-1959R

Original: Nuravax and Institute for Molecular Medicine Announce Publication of Phase 1 Results for AV-1959R Amyloid-Beta Vaccine

Nuravax and the Institute for Molecular Medicine have announced the publication of Phase 1 clinical trial results for AV-1959R, an amyloid-beta vaccine candidate aimed at Alzheimer's disease. The companies say the results are now public, marking an early-stage milestone for the experimental immunotherapy aimed at clearing amyloid plaques.

Why now: Announcement of early-stage clinical data on an experimental Alzheimer's vaccine is drawing attention amid ongoing interest in new dementia treatments.

NuravaxInstitute for Molecular MedicineAV-1959RAlzheimer's disease

Open on news →

Evidence

• Nuravax and Institute for Molecular Medicine Announce Publication of Phase 1 Results for AV-1959R Amyloid-Beta Vaccine · Yahoo Finance
• Nuravax and Institute for Molecular Medicine Announce Publication of Phase 1 Results for AV-1959R Amyloid-Beta Vaccine · PR Newswire

API: https://socialmediatrends-api.osmike.com/v1/trends/2106655